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Abstract
Objective:  This  narrative  review  aimed  to  provide  practitioners  a  synthesis  of  the  current
knowledge  on  the  role  of  a  low  Fermentable  Oligosaccharides  Disaccharides  Monosaccharides
and Polyols  diet  in  reducing  symptoms  associated  with  functional  abdominal  pain  disorders
in children.  This  review  is  focused  on  the  pathophysiology,  efﬁcacy  and  criticism  of  low  Fer-Disaccharides;
Monosaccharides;
Polyol  diet;
Children
mentable Oligosaccharides  Disaccharides  Monosaccharides  and  Polyols  diet  in  children.
Sources:  Cochrane  Database,  Pubmed  and  Embase  were  searched  using  speciﬁc  terms  for  Fer-
mentable  Oligosaccharides  Disaccharides  Monosaccharides  and  Polyols  diet  interventions  and
functional abdominal  pain  disorders.
 Please cite this article as: Pensabene L, Salvatore S, Turco R, Tarsitano F, Concolino D, Baldassarre ME, et al. Low
FODMAPs diet for functional abdominal pain disorders in children: critical review of current knowledge. J Pediatr (Rio J). 2019.
https://doi.org/10.1016/j.jped.2019.03.004
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Summary  of  the  ﬁndings:  In  children,  only  one  Randomized  Control  Trial  and  one  open-label
study reported  positive  results  of  low  Fermentable  Oligosaccharides  Disaccharides  Monosaccha-
rides and  Polyols  diet;  one  Randomized  Control  Trial  showed  exacerbation  of  symptoms  with
fructans  in  children  with  Irritable  Bowel  Syndrome;  no  effect  was  found  for  the  lactose-free
diet whilst  fructose-restricted  diets  were  effective  in  5/6  studies.
Conclusions:  In  children  there  are  few  trials  evaluating  low  Fermentable  Oligosaccharides
Disaccharides  Monosaccharides  and  Polyols  in  functional  abdominal  pain  disorders,  with  encour-
aging data  on  the  therapeutic  efﬁcacy  particularly  of  fructose-restricted  diet.  Additional  efforts
are still  needed  to  ﬁll  this  research  gap  and  clarify  the  most  efﬁcient  way  for  tailoring  dietary
restrictions  based  on  the  patient’s  tolerance  and/or  identiﬁcation  of  potential  biomarkers
of low  Fermentable  Oligosaccharides  Disaccharides  Monosaccharides  and  Polyols  efﬁcacy,  to
maintain nutritional  adequacy  and  to  simplify  the  adherence  to  diet  by  labeling  Fermentable
Oligosaccharides  Disaccharides  Monosaccharides  and  Polyols  content  in  commercial  products.
© 2019  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  This  is  an  open
access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
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Dieta  com  baixo  teor  de  FODMAPs  para  distúrbios  de  dor  abdominal  funcional  em
crianc¸as:  revisão  crítica  do  conhecimento  atual
Resumo
Objetivo:  Nos  últimos  anos,  foram  feitos  esforc¸os  consideráveis  para  esclarecer  o  papel  da
dieta com  baixo  teor  de  Oligossacarídeos  Fermentáveis,  Dissacarídeos,  Monossacarídeos  e  Polióis
(FODMAPs) para  o  tratamento  de  distúrbios  gastrintestinais  funcionais  (DGIFs).  Esta  revisão  nar-
rativa teve  como  objetivo  fornecer  aos  proﬁssionais  uma  síntese  do  conhecimento  atual  sobre
o papel  de  uma  dieta  com  baixo  teor  de  FODMAPs  (BFM)  na  reduc¸ão  dos  sintomas  associa-
dos a  distúrbios  funcionais  de  dor  abdominal  (DFDA)  em  crianc¸as.  Esta  revisão  está  focada  na
ﬁsiopatologia,  eﬁcácia  e  crítica  da  dieta  BFM  em  crianc¸as.
Fontes:  O  banco  de  dados  Cochrane,  Pubmed  e  Embase  foram  pesquisados  utilizando  termos
especíﬁcos para  intervenc¸ões  na  dieta  FODMAP  e  DFDA.
Resumo  dos  achados:  Em  crianc¸as,  apenas  um  estudo  controlado  randomizado  e  um  estudo
aberto relataram  resultados  positivos  da  dieta  BFM;  um  estudo  controlado  randomizado  mostrou
exacerbac¸ão dos  sintomas  com  frutanos  em  crianc¸as  com  Síndrome  do  Intestino  Irritável;  nen-
hum efeito  foi  encontrado  para  a  dieta  livre  de  lactose,  enquanto  dietas  com  restric¸ão  de
frutose foram  eﬁcazes  em  5/6  estudos.
Conclusões:  Existem  poucos  estudos  avaliando  BFM  em  DFDA  em  crianc¸as,  com  dados  enco-
rajadores sobre  a  eﬁcácia  terapêutica,  particularmente  de  dietas  com  restric¸ão  de  frutose.
Esforc¸os adicionais  ainda  são  necessários  para  preencher  esta  lacuna  de  pesquisa  e  esclarecer  a
maneira  mais  eﬁciente  de  adaptar  as  restric¸ões  dietéticas  com  base  na  tolerância  do  paciente
e/ou identiﬁcac¸ão  de  biomarcadores  potenciais  de  eﬁcácia  da  BFM,  para  manter  a  adequac¸ão
nutricional  e  simpliﬁcar  a  adesão  à  dieta,  ao  incluir  informac¸ões  sobre  conteúdo  de  FODMAPs
em rótulos  de  produtos  comerciais.
© 2019  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  Este e´ um  artigo
Open Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-nc-nd/4.
0/).
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he  role  of  diet  is  increasingly  emerging  in  different
astrointestinal  disorders  such  as  functional  gastrointesti-
al  (GI)  disorders  (FGIDs),  irritable  bowel  syndrome  (IBS),
onstipation,  diverticular  disease,  and  inﬂammatory  bowel
isease.1 FGIDs  are  common  disorders  characterized  by
hronic  or  recurrent  GI  symptoms  not  explained  by  bio-
hemical  or  structural  abnormalities.2 The  pathogenesis
f  FGIDs  remains  poorly  understood,  although  a  complex
ltered  interaction  between  gut  and  brain  has  been  recently
dvocated.3 In  the  absence  of  speciﬁc  biomarkers,  FGIDs
F
o
f
lre  clinically  classiﬁed  according  to  the  Rome  IV  diagnos-
ic  criteria,  mainly  based  on  a  thorough  patient  history.4,5
n  children,  FGIDs  may  be  classiﬁed  in  three  main  cat-
gories:  disorders  of  nausea  and  vomiting,  disorders  of
efecation  or  pain-based  (such  as  functional  abdominal
ain  disorders  [FAPDs]).  FAPDs  comprise  four  distinct  dis-
rders:  IBS,  functional  dyspepsia,  abdominal  migraine,  and
AP-not  otherwise  speciﬁed  (FAP-NOS),  meaning  that  the
AP  does  not  ﬁt  the  speciﬁc  diagnostic  pattern  of  one
f  the  ﬁrst  three  disorders.6 Functional  dyspepsia  and  IBS
requently  occur  both  in  children  and  adults.  The  preva-
ence  of  IBS  ranges  from  10  to  25%  of  adults7 and  0
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als  with  methane-producing  microbiota.46,47 Furthermore,ARTICLE
FODMAPs  and  functional  abdominal  pain  in  children  
to  45%  of  children,  respectively.8,9 IBS  strongly  impairs
quality  of  life,  social  functioning,  school  attendance,  and
work  productivity;  it  also  substantially  increases  health
care  costs.  In  the  pathogenesis  of  FGIDs  different  mech-
anisms  have  been  proposed:  increased  pain  sensitivity
or  visceral  hypersensitivity,10,11 abnormal  gut  motility,12
small  intestinal  bacterial  overgrowth,13 low-grade  intesti-
nal  inﬂammation,14 infections,15--17 psychosocial  factors,18
early-life  events,19,20 cow’s  milk  protein  allergy,21,22 and  dys-
regulated  gut--brain  axis.23,24 Familiar  aggregation  of  FGIDs
is  commonly  found  and  may  be  secondary  to  social  learning
and  genetic  factors.25 Gene  variants  coding  for  disaccha-
ridases  with  defective  or  reduced  enzymatic  activity  has
been  recently  found  to  predispose  to  IBS  in  a  subset  of  adult
patients.26 The  gut  microbiome  is  also  recognized  as  a  key
player  in  FGID  and  intestinal  dysbiosis  has  been  reported
in  patients  with  IBS  compared  to  healthy  subjects.27 This
microbial  diversity  could  lead  to  enhanced  intestinal  per-
meability,  mucosal  immune  activation,  altered  gut  motility,
and  visceral  hypersensitivity.27 The  concept  of  a  strict  rela-
tion  between  microbiota  and  immunity,  motility,  nervous
system,  stress,  and  behavior  has  resulted  in  the  joined  term
of  microbiome--gut--brain  axis.  This  axis  has  emerged  as
responsible  for  the  control  and  regulation  of  different  GI
and  neurological  functions.28 In  this  context,  the  importance
of  early  adverse  events  and  diet  has  long  been  recognized.
The  perinatal  period  with  its  pivotal  inﬂuence  in  the  mat-
uration  of  both  gut  and  brain  is  a  critical  period  in  which
different  determinants  may  predispose  to  the  development
of  FGIDs.27
Most  patients  with  FGIDs  report  that  their  GI  symptoms
are  generically  or  speciﬁcally  related  to  food,  although
evidence  of  this  relation  is  often  difﬁcult  to  prove,
particularly  in  children.29--31 Multiple  interacting  and  con-
founding  mechanisms  may  be  involved  in  the  patient’s
perceived  ‘‘food  intolerance.’’  In  IBS  patients,  postpran-
dial  symptoms  can  be  triggered  by  overfeeding,  hyperactive
gastrocolonic  response,  visceral  sensitivity,32,33 dysbiosis,
disordered  gut--brain  signaling,34 anticipation,  allergies,  and
malabsorption.  In  the  absence  of  readily  available,  easy
to  administer,  reliable  ofﬁce-based  tests,  empirical  dietary
restrictions  are  often  indicated  in  the  absence  of  proven
intolerance,  malabsorption,  or  a  conﬁrmed  diagnosis  of  food
allergies.35 This  is  relevant,  as  changes  in  diet  can  interfere
with  the  individual  metabolism,  intestinal  motility,  secre-
tions,  sensitivity,  barrier  function,  gut  microbiota,36 and
adequate  nutrition.  As  expected,  given  the  heterogeneity  of
FGIDs,  individual  patients,  and  underlying  factors,  no  single
treatment  has  shown  to  be  effective  in  all  patients.  Unnec-
essary  diet  restrictions  are  of  particular  concern  in  growing
children.  Therefore,  it  is  of  great  importance  to  have  a  deep
understanding  of  the  evidence  behind  each  dietary  recom-
mendation  given  to  children,  in  order  to  design  personalized
treatment  plans.
In  the  last  years,  great  interest  has  been  focused
on  dietary  fermentable  oligosaccharides,  disaccharides,
monosaccharides,  and  polyols  (FODMAPs)  for  the  treat-
ment  of  FGIDs  in  adults  and  children.  The  low  FODMAPs
(LFM)  diet  restricts  the  intake  of  several  fermentable  car-
bohydrates,  including  foods  containing  fructans  (wheat  and
onion),  galacto-oligosaccharides  (legumes  and  cabbage),
d
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actose  (dairy  products),  fructose  in  excess  of  glucose  (pears
nd  apples),  and  sugar  polyols,  such  as  sorbitol  and  mannitol
stone  fruits  and  artiﬁcial  sweeteners).18 Promising  effect  of
he  low  FODMAP  diet  in  reducing  functional  GI  symptoms  in
dult  patients  has  been  shown,37 but  there  is  limited  evi-
ence  in  children.38
This  narrative  review  explores  the  available  literature
n  LFM  diets  and  aims  to  provide  practitioners  with  a  criti-
al  synthesis  of  the  pathophysiology,  mechanism  of  action,
fﬁcacy,  and  limits  to  help  in  identifying  a diet-tailored
ntervention  for  FAPDs  in  children.
ethods
 literature  search  of  MEDLINE  (via  PubMed),  Embase,
nd  the  Cochrane  Library  databases  was  conducted,  from
nception  to  August  2018,  focusing  on  LFM  diet  in  relation
ith  FAPDs.  The  following  terms  were  queried:  ‘‘FODMAP,’’
‘FODMAPs,’’  ‘‘fermentable  oligosaccharides,  disaccha-
ides,  monosaccharides,  and  polyols,’’  ‘‘fermentable,
oorly  absorbed,  short  chain  carbohydrates,’’  ‘‘lactose-
ree  diet,’’  ‘‘fructose,’’  ‘‘fructans,’’  ‘‘sorbitol’’  AND
‘functional  gastrointestinal  disorders,’’  OR  ‘‘functional
bdominal  pain,’’  ‘‘recurrent  abdominal  pain,’’  ‘‘irritable
owel  syndrome,’’  ‘‘IBS.’’  The  authors  restricted  the  search
o  English  language  and  children  (aged  0--18  years).  Because
he  purpose  of  this  review  was  not  to  duplicate  a  recent  sys-
ematic  review  on  FODMAPs  but  rather  to  critically  review
he  available  literature  and  provide  the  clinicians  a practi-
al  summary  of  LFD  in  children,  the  search  was  expanded  to
nclude  prospective  and  retrospective  studies,  randomized
ontrolled  trials  (RCTs),  reviews,  and  editorials.
ODMAPs
hroughout  the  1980s  and  1990s,  clinical  studies  focused
rimarily  on  the  role  of  lactose,  fructose,  and  sorbitol
ntake  as  triggers  of  GI  symptoms  including  abdominal  pain,
iscomfort,  bloating,  distension,  and  diarrhea.  In  recent
ears,  the  focus  has  shifted  to  fructo-oligosaccharides  (FOS)
fructans)  and  galacto-oligosaccharides  (GOS)  ingestion  as
ossible  culprits  of  IBS.39 Grouping  all  these  fermentable
hort-chain  carbohydrates  and  sugar  alcohols  together  led
o  the  acronym  FODMAPs.  Poor  absorption,  osmotic  activ-
ty,  and  rapid  fermentation  by  the  luminal  microbiome40
ay  result  in  excessive  gas  production,41 luminal  disten-
ion,  loose  stools,  and  visceral  hypersensitivity,  features
hat  are  consistent  with  IBS.  Moreover,  small  intestinal  bac-
erial  overgrowth  that  may  occur  in  some  patients  with  IBS
an  increase  the  metabolism  of  these  carbohydrates  and
onsequent  gas  production.39 Symptoms  related  to  FODMAPs
ay  also  derive  from  changes  in  the  gut  microbiota  and
etabolism,  endocrine  cells,  immune  function,  and  intesti-
al  barrier.42--45 Intriguingly,  a  non-restrictive  FODMAP  diet
ay  be  both  associated  with  loose  stools  and  with  delayed
ut  transit  time  and  constipation,  as  occurs  in  individu-ietary  intake  of  carbohydrate-related  prebiotics  (ﬁbers)
nteracting  with  intestinal  probiotics  may  have  beneﬁcial
ffects  on  human  health48,49 (Fig.  1) .
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the  ﬁrst  phase  of  FODMAP  restriction,  if  a  therapeuticFigure  1  Mechanism  of  action  of  carbohydrate-relate
Modiﬁed  from:  Nath  et  
The  LFM  diet  was  ﬁrst  developed  in  1999  by  Dr.  Gibson
nd  Dr.  Shepard  at  Monash  University  in  Melbourne.  In  2005,
he  same  authors  proposed  that  a  diet  high  in  FODMAPs
ight  perpetuate  (functional)  gastrointestinal  symptoms
n  patients  with  Crohn’s  disease.50 This  concept  was  soon
xtrapolated  to  IBS  patients.  Early  studies  showed  the
ositive  effects  of  fructose  and  short-chain  fructans  restric-
ion  in  adults  with  fructose  malabsorption.  Moreover,  the
o-ingestion  of  fructose  and  glucose  counteracts  the  detri-
ental  effect  of  the  excess  of  free  fructose  in  the  small
ntestine  of  IBS  patients  with  fructose  malabsorption  due  to
acilitated  combined  transport.51 Since  then,  multiple  tri-
ls  have  been  conducted  and  LFM  is  currently  considered  an
ffective  dietary  approach  in  adults  with  IBS,39 particularly
hen  symptoms  persist  despite  lifestyle  changes  and  other
ietary  advice.52 FODMAPs  are  present  in  foods  contain-
ng  wheat,  rye,  barley,  legumes,  lentils,  chickpeas,  Brussels
prouts,  asparagus,  artichokes,  beets,  broccoli,  cabbage,
ennel,  onions,  garlic,  leeks,  okra,  peas,  shallots,  apples,
eaches,  persimmon,  watermelon,  and  pistachios.53 A  list
f  food  with  low  FODMAP  content  is  shown  in  Table  1.54--59
A  study  in  ileostomates  clariﬁed  that  the  fermentable
oad  and  volume  of  liquid  delivered  to  the  large  intes-
ine  are  increased  by  FODMAPs.40 The  gut  microbiota
apidly  ferment  carbohydrates,  resulting  in  luminal  dis-
ension  and  abdominal  pain  in  adults  with  visceral
ypersensitivity.  A  scintigraphic  study  demonstrated  that
ructose--sorbitol  ingestion  reduced  the  oro-cecal  tran-
it  time  by  approximately  3  h  in  healthy  individuals.60
ther  studies  showed  that  FODMAPs  can  change  the
icrobiota  composition,  decrease  urinary  histamine,61
nd  increase  pro-inﬂammatory  cytokines62 and  visceral
ociception.63 A  diet  high  in  FODMAPs  (HFM)  increased
at  fecal  Gram-negative  bacteria,  elevated  lipopolysaccha-
ides,  and  induced  intestinal  barrier  dysfunction  and  visceral
r
r
tbiotics  +  probiotics  and  their  effects  on  human  health.
and  Markowiak  et  al.49
ypersensitivity.63 A  four-week  LFM  diet  was  able  to  reverse
hese  manifestations,  improving  IBS  symptoms  and  reducing
ecal  lipopolysaccharides  levels.  Intracolonic  administration
f  fecal  supernatant  from  IBS  patients  to  rats  caused  visceral
ypersensitivity  in  the  animals,  which  was  not  transferred  if
he  patients  were  on  an  LFM  diet.63
he LFM diet: practical steps
 LFM  diet  can  be  implemented  following  two  different
pproaches:  bottom-up  and  top-down.64 The  bottom-up
pproach  is  a  progressive  gradual  elimination  of  single  prod-
cts  (or  groups  of  products)  from  the  diet  until  the  symptoms
re  alleviated  and  allows  specifying  the  patient’s  limit  of  tol-
rance  for  FODMAPs.  This  method  is  preferred  in  patients:
1)  who  have  not  yet  been  diagnosed  with  IBS  but  experience
uggestive  symptoms  affecting  their  quality  of  life;  (2)  who
re  already  on  other  elimination  diet;  or  (3)  who  struggle  to
ollow  a  full  LFM.65 The  second  approach,  top-down,  more
ommonly  used  in  experimental  studies,  require  transient
eduction  or  elimination  of  all  foods  high  in  FODMAPs  from
he  diet,  being  therefore  far  more  restrictive.  Next,  prod-
cts  containing  FODMAPs  are  gradually  reintroduced  into  the
iet.65,66
In  an  LFM  diet,  there  are  three  distinct  phases:
limination,  determination  of  sensitivities,  and
ersonalization.36,67,68 The  majority  of  the  studies  con-
ucted  on  the  LFM  diet  have  focused  on  the  elimination
hase,  usually  prescribed  for  two  to  six  weeks,  followed
y  assessment  of  symptom  improvement.  After  completingesponse  is  achieved,  patients  should  undergo  a  structured
eintroduction  phase  (ideally  with  the  help  of  a dietitian)
o  determine  the  type  and  amount  of  FODMAPs  that  can
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Table  1  List  of  foods  with  low  fermentable  oligosaccharides,  disaccharides,  monosaccharides,  and  polyols  (FODMAP)  content.
Nutrients  Low  FODMAP  content
Cereals  Gluten  free  products,  rice,  corn  pasta,  tortilla  chips,  quinoa,  oats,  polenta,  sourdough,
noodles
Milk products
Cheese
Lactose  free  products,  rice  milk,  soy  milk,  sorbets
Hard  cheeses,  Cheddar,  Parmesan,  mozzarella,  Swiss,  ﬁrm  tofu,  tempeh,  Brie,  Camembert
Fruits Bananas,  cantaloupe,  carambola,  durian,  honeydew  melon,  kiwi,  orange,  passion  fruit,
pawpaw, all  berries  (raspberries,  blueberries,  cranberries,  strawberries)  except  than
blackberries,  tangelo,  grapes,  grapefruit,  all  nuts  (except  cashew  and  pistachios,  and  less
than ten),  almonds  (less  than  10),  macadamia,  olives,  pumpkin  seeds,  ﬂax  and  chia  seeds,
coconut, lemon,  limes,  papaya,  rhubarb
Vegetables  Bamboo  shoot,  bok  choy,  capsicum,  celery,  chives,  choko,  choy  sum,  corn,  eggplant,  green
bean, bean  sprouts,  lettuce,  parsnip,  pumpkin,  silverbeet,  tomato,  potatoes,  spring  onion
(green part  only),  garlic-infused  oil,  bell  peppers,  Swiss  chard,  carrots,  spinach,  zucchini,
beet root  (no  more  than  four  slices),  broccoli  (no  more  than  1/2  cup)
Legumes Canned  pumpkin,  canned  chickpeas,  canned  lentils
Sweeteners  Honeydew,  golden  syrup,  maple  syrup,  glucose,  sucrose  (table  sugar),  aspartame,  stevia,
molasses, any  sweeteners  not  containing  fructose  and  not  ending  in  ‘‘-ol’’
References  Khan  et  al.,  201554;  Barrett  201755;  Varney  et  al.,  201756;  Monash  University  Low  FODMAP  Diet
App. 201657;  Canadian  Digestive  Health  Foundation  201958;  Magge  and  Lembo,  201259
Note: FODMAP composition is affected by food processing techniques. Processes that involve heating and water can reduce the content
of water soluble FODMAPs (such as fructans and GOS) leaching into the surrounding liquid (canned legumes are lower in FODMAP, GOS,
than boiled legumes). Servings should also be considered because an excessive intake may increase the content of FODMAP diet (i.e.,
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falmonds and other nuts, if less than ten pieces, are low in FODMA
low-FODMAP except if they contain honey or fructose, or polyol s
be  tolerated  before  experiencing  symptoms,  thus  creating
a  personalized  LFM  diet.67 With  this  approach,  based  on
tailored  dietary  restrictions  demonstrated  by  the  patient’s
tolerance,  nutritional  adequacy  is  more  likely  to  be  main-
tained  and  alterations  of  the  luminal  microbiota  may  be
partially  offset.69
FODMAP  content  guidance  is  available  via  scientiﬁc  and
lay  publications  for  many  types  of  foods70;  the  majority
of  information  and  analysis  originated  in  Australia.71 The
discordance  of  FODMAP  content  in  other  countries  food
lists  could  be  partly  related  to  the  lack  of  clear  FODMAP
content  guidance  in  different  geographical  areas.72 Chumpi-
tazi  et  al.70 found  an  excessive  FODMAP  content  in  several
processed  foods,  previously  considered  as  LFM  foods,  such
as  gluten-free  baked  products  and  manufactured  beverages.
Also,  in  Australian  manufactured  gluten-free  bread,  the
fructose  content  is  sometimes  higher  than  the  nongluten-
free  counterparts.73 Appropriate  assessment  of  FODMAPs
and  fructose  and/or  fructans  may  be  helpful  for  patients
with  different  tolerance  to  different  carbohydrate.74 The
development  of  technologies  enabling  the  reduction  of
FODMAPs  in  processed  food  is  also  recommended.64
Criticisms of the low FODMAP diet
Despite  the  demonstrated  effectiveness  of  the  LFM  diet  in
a  subset  of  patients  with  IBS,  multiple  concerns  have  been
raised.64,75 Those  include:  (1)  the  lack  of  high-quality,  ran-
domized,  placebo-controlled  trials  in  children76--78;  (2)  the
complexity  and  difﬁculty  of  teaching  the  diet;  (3)  the  lack
of  speciﬁc  cut-off  levels  for  FODMAP  content;  (4)  the  paucity
of  data  on  safety  and  long-term  efﬁcacy;  and  (5)  its  effect
on  the  gut  microbiota.79
c
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Irge bananas have increased FODMAP).a Gluten free products are
ners.
In  addition  to  the  impact  on  nutrient  intake,  the  LFM  diet
ay  have  psychosocial  impacts.  Patients  have  reported  ﬁnd-
ng  the  diet  ‘too  demanding  to  follow’,80 and  a  questionnaire
tudy  reported  difﬁculty  in  eating  out  and  traveling  for  those
ollowing  a  long-term  FODMAP  diet.81
However,  the  beneﬁcial  effects  of  the  LFM  diet  on
uality  of  life  have  been  demonstrated.82,83 Despite  the  per-
eived  complexity  of  following  such  a  restrictive  diet,83 57%
f  patients  reported  adequate  relief  of  symptoms.  Of  90
atients  enrolled  in  a  prospective  observational  study,  60%
tated  that  the  LFM  diet  was  easy  to  follow.84
In  terms  of  safety,  major  concerns  regard  possible
utrient  deﬁciencies,  particularly  during  the  initial  elimi-
ation  phase  of  high  FODMAP  containing  foods.79 Reduced
ntake  of  grains,  fruits,  vegetables,  and  dairy  products
an  restrict  dietary  choices,  and  may  result,  especially
n  growing  children,  in  weight  loss,  failure  to  thrive,  risk
f  ﬁber  and  micronutrient  deﬁciencies  (mainly  iron,  cal-
ium,  retinol,  thiamin,  and  riboﬂavin),83,85--87 and  eating
isorders  such  as  poor  eating  habits  and  food  aversions.  In
he  largest  RCT  on  LFM  diets79 the  energy  intake  was  not
ifferent  to  those  following  normal  diet,  and  the  change
n  body  weight  was  minimal  (mean  <  0.5  kg)  and  not  dif-
erent  between  both  groups.83,85 Conversely,  two  other
-week  RCTs  reported  reduction  in  energy  intake  in  the
FM  group.44,86,87 Moreover,  some  FODMAP-rich  vegetables
e.g.,  cauliﬂower,  onion,  garlic)  contain  natural  antioxi-
ants,  such  as  ﬂavonoids,  carotenoids,  and  vitamin  C;  some
ruits  and  blackberries  contain  phenolic  acid  and  antho-
yanins,  and  wheat  is  a  major  source  of  phenolic  acids.88,89owever,  a  recent  follow-up  study  demonstrated  no  nutri-
ional  inadequacies  following  the  reintroduction  period  in
BS  patients  on  an  ‘adapted  FODMAP’  diet.69 Additionally,
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he  only  two  long-term  studies  in  patients  with  IBS  follow-
ng  a  personalized  FODMAP  diet  with  FODMAP  reintroduction
ccording  to  patients’  tolerance,  found  that  calcium,81,82
ron,  and  other  micronutrients81 were  not  compromised  at
--18  months.
Two  RCTs  in  adults  with  IBS29,86 and  a  small,  uncontrolled
rial  in  patients  with  radiation-induced  gastrointestinal
ymptoms80 reported  reductions  in  ﬁber  intake  during  the
FM  diet  compared  with  baseline.  Inadequate  substitution  of
igh  FODMAP  grains  and  fruit  and  vegetables  with  suitable
FM/high-ﬁber  replacements  could  explain  these  ﬁndings.
oreover  another  large  RCT  found  no  difference  in  ﬁber  or
acronutrient  intake  after  a  four-week  LFM  diet  in  IBS.85
he  nutritional  impact  may  vary  mostly  due  to  the  avail-
bility  of  alternative  food  choices,  and  the  completeness  of
ietary  advice  given.
About  the  inﬂuence  of  diet  on  the  gut  microbiome,
pecies  considered  beneﬁcial  for  host  health,  such  as  biﬁ-
obacteria  and  Faecalibacterium  prausnitzii, were  reduced
n  IBS  patients  receiving  a  LFM  diet,  most  likely  as  a
onsequence  of  reducing  prebiotic  intake.34 The  abun-
ance  of  several  bacteria  (F.  prausnitzii,  Actinobacteria,
nd  Biﬁdobacterium)  rebounded  after  ten  days  of  FOS
upplementation62 and  the  strain  diversity  did  not  decrease
ith  FODMAP  restriction  in  four  studies.61,87,90,91 Moreover,
taudacher  et  al.83 found  that  the  reduction  in  Biﬁdobac-
erium  induced  by  a  LFM  diet  was  counteracted  through  a
peciﬁc  probiotic  preparation  containing  biﬁdobacteria.
vidence for using LFM diets to manage
astrointestinal symptoms in adults
 recent  systematic  review38 has  found  that  in  12  out  of  13
rials  in  adults,  a  FODMAPs-restricted  diet  was  an  effective
ietary  intervention  for  reducing  IBS  symptoms.  However,  a
ecent  RCT  has  shown  that  although  the  LFM  diet  reduced
ymptoms  of  IBS,  it  was  no  better  than  traditional  dietary
dvice.44 Another  trial  found  that  the  proportion  of  sub-
ects  reporting  adequate  relief  of  IBS-D  symptoms  by  ≥50%
primary  end  point)  during  weeks  three  and  four  did  not
igniﬁcantly  differ  from  those  not  receiving  an  LFM  diet.87
In  athletes  with  a  self-reported  history  of  persistent  exer-
ise  associated  GI  distress,  a  short-term  LFM  resulted  in
ower  daily  GI  symptoms  compared  with  a  high  FODMAP
iet.92
vidence for using LFM diets to manage FAPDs
n children
he  pediatric  literature  search  retrieved  156  records  and,
ccording  to  the  selected  inclusion  criteria,  24  records  were
ncluded  in  this  review  (Fig.  S1).
vidence  for  comprehensive  LFM  diet  in  children
ith FAPDshe  summary  of  the  studies  in  children  is  shown  in  Table  2.
In  a  open-label  study,93 conducted  in  a  small  sam-
le  of  eight  children  with  IBS,  abdominal  pain  severity,
m
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n
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ntensity,  and  interference  with  daily  activities  were  signiﬁ-
antly  reduced  after  one  week  of  LFM  diet.  Four  out  of  eight
hildren  had  ≥50%  decrease  in  abdominal  pain  frequency
s  compared  to  the  baseline.93 In  a  randomized  double-
lind  crossover  trial,90 33  children  with  IBS  were  randomized
o  receive  a  LFM  diet  (0.15  g/kg/day,  maximum  9  g/day  of
ODMAPs)  or  a  typical  American  childhood  diet  (TACD)  con-
aining  0.7  g/kg/day  (maximum  50  g/day)  of  FODMAPs  for
8  h.  After  a  ﬁve-day  washout  period,  the  children  were
‘crossed  over’’  to  the  other  diet  for  another  48  h.  Chil-
ren  on  LFM  diet  reported  signiﬁcantly  lower  number  of  daily
pisodes  of  abdominal  pain  compared  to  children  following
ACD.  Children  who  had  signiﬁcant  improvement  on  the  LFM
iet  had  a  distinct  microbiota  proﬁle  showing  enriched  taxa
ith  a  major  saccharolytic  metabolic  function  (e.g.  Bac-
eroides,  Ruminococcaceae,  F.  prausnitzii). No  difference
n  -diversity  (number  of  operational  taxonomic  units,  i.e.,
umber  of  species)  has  been  found  after  a  one-week  LFM
iet.  In  a  subsequent  editorial,94 the  authors  hypothesize
hat  a  larger  effect  size  could  have  been  found  with  a  longer
rial  comparing  the  LFM  and  the  TACD.
A  recent  study  in  adults  with  IBS  conﬁrmed  that
re-treatment  levels  of  selected  gut  microbial  DNA  mark-
rs  (higher  levels  of  Bacteroides  fragilis, Acinetobacter,
uminiclostridium,  Streptococcus, and  Eubacterium) were
ssociated  with  higher  probability  to  respond  to  FODMAP
estriction.95
Two  recent  reviews38,96 highlighted  the  limited  data  avail-
ble  in  children,90,97 and  the  need  of  larger,  high  quality
tudies  to  test  the  effectiveness  of  the  LFM  diet.
A  recent  pediatric  single-blind,  open-label,  interven-
ional  proof-of-concept  study98 assessed  the  efﬁcacy  of  an
nnovative,  alternative  approach.  In  this  study,  18  exclu-
ively  breastfeeding  healthy  full-term  infants  aged  2--17
eeks  who  met  criteria  for  infantile  colic  and  their  mothers
ere  recruited  for  a  dietary  intervention  trial.  The  infant’s
others  were  delivered  a  seven-day  LFM  diet  and  com-
leted  the  Baby  Day  Diary  on  days  ﬁve  through  seven  to
ssess  clinical  study  outcomes,  and  used  a  stopwatch  to
easure  duration  of  sleep,  feeding,  crying,  fussiness,  and
wake  and  content  times.  FODMAP  content  of  breast  milk
nd  infant  fecal  samples  for  pH  were  analyzed  at  baseline
nd  at  the  end  of  the  dietary  intervention.  Crying  dura-
ion  decreased  by  52  min  compared  to  baseline  [142  min]
y  the  end  of  the  dietary  trial.  Signiﬁcant  reductions  in
uration  of  fussiness  and  in  number  of  episodes  of  cry-
ng  were  also  reported.  The  analysis  of  breast  milk  lactose
ontent  was  found  to  be  stable  throughout  the  intervention.
tool  pH  of  infants  was  unchanged  from  baseline.  Despite
he  lack  of  evidence,  many  breastfeeding  mothers  tend  to
ractice  a  dietary  change  as  a  common  strategy  to  relieve
heir  infant’s  colic  symptoms,99--102 in  some  cases  avoid-
ng  gas-producing  foods  (e.g., onions,  garlic,  cabbage,  or
egumes/pulses).101,102
Restricted  diets,  such  as  the  LFM  diet,  need  to  be  man-
ged  and  supervised  appropriately  in  both  breastfeeding
others  and  growing  children,  and  in  consultation  with  a
pecialized  dietitian,  as  they  can  lead  to  a compromised
utritional  adequacy  and  also  to  the  development  of  poor
ating  behaviors  and  food  fears.
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Table  2  Characteristics  of  the  fermentable  oligosaccharides,  disaccharides,  monosaccharides,  and  polyols  (FODMAP)  pediatric  studies  included  in  the  review.
Study  Methodology  Participants Intervention  Duration
of  diet
Outcome
measures  and
instruments
Key  results
Chumpitazi
et  al.,  201493
Open-label
prospective  study
Children  aged
7--17  years
(n  =  8)  with  IBS
Low  FODMAP
diet
7  days Frequency  of  pain
episodes;
Instruments:  Stool
and  Pain  Diaries
Signiﬁcantly  (p  <  0.05)  reduction  in  pain  frequency,  pain
severity,  and  pain-related  interference  with  activities.  >
50% decrease  in  abdominal  pain  frequency  was  obtained
with  the  LFD  in  four  children  (50%)  identiﬁed  as
responder
Chumpitazi
et al.,  201590
Randomized,
double-blind,
cross-over  study,
with  wash-out
period
Children  aged
7--17  years
(n  =  33)  with  IBS
Low  FODMAP
vs.  TACD  diet
2  days Children  pain
episodes
frequency;
Instruments:  Pain
and  Stool  Diary
16  children  were  initially  treated  with  the  low  FODMAP
diet  while  17  began  with  the  TACD;  children  on  low
FODMAP  reported  a  decrease  in  daily  abdominal  pain
episodes  vs.  children  on  following  TACD  [1.1  ±  0.2  (SEM)
vs. 1.7  ±  0.4  pain  episodes  per  day,  respectively;
p <  0.05].
Chumpitazi
et al.,
2018108
Double-blind
placebo-controlled
(maltodextrin)
cross-over  trial
with  wash-out
Children  with
mean  age
12.4  +  2.2  years
(n =  23)  and  IBS
Fructans  or
maltodextrin
(0.5  g/kg;
maximum,
19 g).
3  days Children  pain
episodes
frequency;
Instruments:  Pain
and  Stool  and
Food  Diaries
The  fructan-containing  diet  was  associated  with
signiﬁcantly  more  severe  bloating  and  ﬂatulence  and
more mean  episodes  of  abdominal  pain/day  (3.4  −  2.6)
compared  to  the  maltodextrin-containing  diet
(2.4 −  1.7)  (p  <  0.01).  More  frequent  abdominal  pain
while on  the  fructan-containing  diet  has  been  reported
by  18  children  (78.2%)  and  12  (52.2%)  qualiﬁed  as
fructan  sensitive  (deﬁned  as  an  increase  of  ≥30%
abdominal  pain  frequency  following  fructan  ingestion);
Däbritz et  al.,
2014124
Retrospective
study
Children  aged
3--18  years  with
RAP  (n  =  206)
Lactose,
fructose  and/or
sorbitol
restricted  diet
longer
than  12
months
in  55
patients
[47%]
Improvement  of
symptoms;
Instruments:
follow-up
questionnaire
Sorbitol  malabsorption  has  been  diagnosed  in  109/146
(75%)  children;  27/31  (87%)  had  an  improvement  on  a
sorbitol-restricted  diet.
55/142  (39%)  children  had  fructose  malabsorption.  The
number  of  children  who  speciﬁcally  responded  to  a
fructose-restricted  diet  is  unclear,  due  to  several
patients  in  this  cohort  having  multiple  positive
carbohydrate  tests
Dearlove et  al.,
1983109
Prospective  study  Children  aged
>3  years  with
RAP  (n  =  39)
Lactose
restricted  diet
2  weeks  Improvement  of
symptoms;
Instruments:  not
speciﬁed
One-third  of  the  children  reported  beneﬁt  from  the
lactose  free  diet,  but  no  correlation  was  found  with
results  of  the  lactose  tolerance  test,  breath  hydrogen
estimation,  or  response  to  lactose  challenges
Escobar et  al.,
2014131
Retrospective
study
Children  aged
2--  19  years
with  RAP
(n  =  222)
Low-fructose
diet
2  months
(not
clearly
specify)
Improvement  of
symptoms;
Instruments:  Pain
scale  score
93/121  patients  (76.9%)  with  BTH  positive  reported
resolution  of  symptoms  on  a  low-fructose  diet
(p <  0.0001)  compared  to  55/101  patients  (54.4%)  with
negative  BHT  for  fructose  (p  =  0.37).
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Table  2  (Continued)
Study  Methodology  Participants  Intervention  Duration
of  diet
Outcome
measures  and
instruments
Key  results
Gijsbers  et  al.,
2012122
Prospective  study
with  DBPC  test  of
provocation
Children  aged
4--16  years  with
RAP  (n  =  220)
Low-lactose
and/or  fructose
diet
3  days  of
provoca-
tion
test
Resolution  of
abdominal  pain
with  elimination,
recurrence  with
provocation  and
disappearance
with  re-
elimination;
Instruments:  not
speciﬁed
Pain  resolved  upon  elimination  in  24/38  patients  with
lactose  malabsorption,  and  in  32/49  with  fructose
malabsorption.  A  positive  open  provocation  with  lactose
and fructose  has  been  reported  in  7/23  and  13/31
patients.  DBPC  provocation  test  done  in  6/7  and  8/13
patients  was  negative  in  all,  but  a  few  children
continued  to  report  abdominal  symptoms  upon  intake  of
milk or  fructose.
Gomara et  al.,
2008128
Prospective  study  Children  aged
7--17  years
(n  =  32)  FGIDs
Low-fructose
and
low-sorbitol
diet
2  weeks  Improvement  in
their  GI  symptoms;
Instruments:  not
speciﬁed
9  of  11  patients  (81%)  with  positive  fructose  breath  test
results,  reported  almost  immediate  improvement  in  GI
symptoms  but  a  signiﬁcant  reduction  only  for  abdominal
pain  and  bloating  (p  <  0.05)
Gremse et  al.,
2003111
Randomized,
double-blind,
cross-over  study
Children  aged  3
--17  years  with
RAP
(n  =  30)
Lactose-
hydrolyzed  or
lactose-
containing
milk
14  days  Improvement  in
their  GI  symptoms;
Instruments:  Daily
diaries
A  signiﬁcant  increase  in  abdominal  pain  was
experienced  by  study  participants  during  the  lactose
ingestion  period  when  compared  to  the  lactose-free
period  (total  scores  7.5  +  2.7  vs.  4.1  +  1.4,  p  =  0.021)
Hammer et  al.,
2018130
Prospective  trial  Children  with
RAP,  with
history
suggestive  of  a
possible
association  of
symptoms  with
fructose
ingestion
(n  =  82)
Fructose
breath  testing
using:  1  g/kg
body  weight  up
to maximum  of
25 g
--  Severity  of  clinical
symptoms.
Instruments:
symptom
questionnaire
A  total  of  33  children  (40%)  had  malabsorption;  fructose
ingestion  induced  symptoms  in  31  (38%),  but  only  15
(46%)  with  malabsorption  were  symptomatic;  fructose
malabsorption  did  not  signiﬁcantly  correlate  with
fructose-induced  symptoms;  clinical  symptoms
correlated  only  with  symptoms  experienced  during  the
breath  test  (p  <  0.001,  r2 =  0.21)  but  not  with
malabsorption  (NS)
Iacovou et  al.,
201898
Single-blind,
open-label,
interventional
study.
Exclusively
breastfeeding
mothers  and
their  infants
aged  2--17
weeks  who  met
the  Wessel
Criteria  for
infantile  colic
(n  =  18)
Maternal  low
FODMAP  diet
7  days  Infant
crying-fussing
durations
(minutes),
Instruments:  Baby
Day  Diary
Infant  crying-fussing  durations  fell  by  73  [301--223]  min
(n =  13;  p  =  0.007),  as  well  as  crying  episodes  (p  =  0.01)
and fussing  durations  (p  =  0.011).
‘‘Much  more  content’’  babies  were  reported  at  end  of
study  by  their  mothers
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(Continued)
Study  Methodology  Participants Intervention  Duration
of  diet
Outcome
measures  and
instruments
Key  results
Lebenthal
et  al.,
1981110
Prospective  study Children  aged
6--14  years
(n  =  69)  RAP
Low-lactose
diet
12
months
Improvement  in
RAP;  Instruments:
Symptoms  Diary
Symptoms  of  RAP  resolved  in  40%  lactose  malabsorbers,
in 38.4%  lactose  absorbers  after  12  months  of
elimination  diet  and  in  41.7%  lactose  absorbers
following  a  regular  diet.
Wintermeyer
et al.,
2012129
Prospective  study Children  aged
3--14  years
(n  =  75)  with
RAP
Low-fructose
and
low-sorbitol
diet
4  weeks Improvement  of
frequency  and
intensity  of
abdominal  pain;
Instruments:
nonstandard
questionnaire
A  median  reduction  of  weekly  pain  frequency  from  a
mean  of  3.64  +  1.6  before  diet  to  a  mean  of  1.46  +  1.4
(p <  0.001)  under  fructose  restriction  was  reported.
The median  intensity  of  pain  decreased  from  6  (mean
5.83  +  2.0)  before  intervention  to  3  (mean  3.4  +  2.5;
p <  0.001)  on  diet.  A  signiﬁcant  improvement  of  daily
stool frequency,  nausea,  sleep  problems,  missed  school
days was  also  reported  on  diet
Wirth et  al.,
201497
Prospective,
blinded
randomized
interventional
trial
103  children
with  RAP:
51  restricted
diet  (group  A),
52  standard
diet  (group  B)
Fructose-
restricted  diet
vs.  standard
diet
2  weeks 1.  Pain  intensity
(measured  by
questionnaire)
2. Pain  frequency
(as  above)
3.  ‘‘Secondary
symptoms  score’’
(SSS)  created  from
8  parameters
(nausea,  vomiting,
fatigue,  sleep
disturbance,
headache,
dizziness,
anorexia,  and  use
of  pain  relievers).
There  was  a  signiﬁcant  decrease  on  pain  score  (from  a
median  5.5  to  4)  in  group  A  and  no  signiﬁcant  changes  in
group B  (5.3--5)  two  weeks  after  intervention.
Frequency  of  abdominal  pain  decreased  in  both  groups
but without  signiﬁcant  difference,  while  SSS  improved
only in  group  A  from  median  6  to  3.5.
IBS, irritable bowel syndrome; RAP, recurrent abdominal pain; TACD, typical American childhood diet; LFD, low FODMAP diet; BHT, breath hydrogen test; DBPC, double blind placebo
controlled.
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0  
ructans-related  studies  in  children  with  FAPDs
ructans  are  FODMAPs  commonly  present  in  the  usual
iet  of  adults  and  children.103 Fructans  are  rich  in
ructosyl--fructose  linkages  that  reach  intact  the
olon  intact,  as  they  cannot  be  hydrolyzed  by  human
nzymes.103--105 These  oligosaccharides  undergo  colonic
ermentation,  increasing  gas  production  and  subsequent
uminal  distension,  which  can  exacerbate  symptoms  in
ndividuals  with  IBS.42,106 However,  limiting  fructans  may
educe  healthy  foods  (i.e.,  ﬁbers)  and  Biﬁdobacteria.104,107
In  a  recent  double-blind,  randomized,  placebo-
ontrolled  crossover  trial,108 23  children  with  IBS  completed
 one-week  baseline  abdominal  pain  and  stool  diaries
nd  three-day  food  diaries.  Depression,  anxiety,  and
omatization  scores  were  measured  through  validated
uestionnaires.  Children  were  randomly  assigned  to  receive
eals  containing  either  fructans  or  maltodextrin  (0.5  g/kg;
aximum,  19  g)  for  72  h  followed  by  a  washout  period  of  at
east  ten  days.
Breath  hydrogen  and  methane  production  were  tested  at
aseline  and  during  each  study  period.  Fructan-sensitive  and
ructan-insensitive  subjects  were  similar  in  baseline  symp-
oms  and  diet,  psychosocial  evaluation,  IBS  subtype,  and
as  production.  There  were  a  signiﬁcantly  higher  number
f  daily  abdominal  pain  episodes,  more  severe  bloating,
nd  ﬂatulence  during  the  fructan-containing  diet  compared
o  the  maltodextrin-containing  diet.  Hydrogen  (but  not
ethane)  production  was  signiﬁcantly  higher  during  the
ructan  period).
actose-related  studies  in  children  with  FAPDs
hree  RCT  on  a  restricted  lactose  diet  have  been
ompleted109--111 in  children  with  FAPDs112 as  well  as  a  larger
umber  of  observational  or  uncontrolled  trials.113--124 Most
f  the  older  studies  were  conducted  using  old  terminology
f  recurrent  abdominal  pain  (RAP).  Two  out  of  the  three  RCT
rials  on  lactose-free  diet  that  were  conducted  in  children
ith  RAP109,110 were  evaluated  by  a  Cochrane  Review,125 and
ncluded  in  a  systematic  review  by  Rutten  et  al.126
Lebenthal  et  al.110 studied  the  effect  of  lactose  intol-
rance  in  RAP  through  an  uncontrolled  treatment  and  a
andomized  controlled  challenge.  Thirty-eight  of  69  chil-
ren  with  lactose  intolerance  received  six  weeks  of  either
actose-containing  or  lactose-free  infant  formula.  Lactose
ntake  increased  symptoms  in  48%  of  the  lactose  malab-
orbers  and  in  24%  of  the  lactose  absorbers.  Forty  of  the
9  children  continued  with  lactose  free  diet  for  12-months.
fter  12  months,  improvement  of  abdominal  pain  was  simi-
ar  in  both  groups  regardless  if  they  were  lactose  absorbers
r  malabsorbers  (40%  vs.  38%).
In  another  double  blind,  single  crossover  design  trial  con-
ucted  in  39  children  with  RAP,109 children  were  instructed
o  continue  with  their  usual  diet  for  the  ﬁrst  two  weeks,
hile  during  the  third  and  fourth  weeks  they  received  a
actose-free  diet,  and  during  the  ﬁfth  and  sixth  weeks
he  children  randomly  received  either  lactose  (2  g/kg)  or  a
imilarly  ﬂavored  placebo.  One-third  of  the  children  were
eported  to  have  beneﬁtted  from  the  lactose-free  diet,  but
here  was  no  correlation  between  the  improvement  and  the
s
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esults  of  the  lactose  tolerance  blood  test,  breath  hydrogen
est,  or  clinical  response  to  lactose  challenge.
In  2003,  Gremse  et  al.111 conducted  a randomized,
ouble-blinded,  cross-over  study.  Thirty  children,  aged  3--17
ears,  affected  by  RAP  and  lactose  maldigestion  deﬁned  by
10-ppm  increase  in  lactose  breath  hydrogen  test  received
ither  lactose-hydrolyzed  or  lactose-containing  milk  for  two
eeks.  Abdominal  pain,  bloating,  ﬂatulence,  and  diarrhea
cores  were  similar  in  subjects  who  had  >10-ppm  or  >20-ppm
ncrease  in  breath  hydrogen  testing  after  ingesting  lactose.
ue  to  the  conﬂicting  results  of  the  above  studies,  further
rospective  RCTs  are  necessary  to  clarify  the  efﬁcacy  of  a
actose-restricted  diet  in  children  with  AP-FGIDs  who  have
actose  malabsorption,93 whereas,  according  to  a  recent  sys-
ematic  review38 the  current  evidence  in  the  literature  does
ot  encourage  the  use  of  a  lactose-restricted  diet  in  all  chil-
ren  with  IBS.  Data  in  adult  studies  are  also  inconclusive,
nd  it  is  still  unclear  if  the  lactose  malabsorption  is  part
f  the  IBS  symptoms,  or  if  the  two  conditions  may  simply
oexist  in  some  patients.38
ructose-related  studies  in  children  with  FAPDs
ructose  is  a  monosaccharide,  of  which  American  children
onsume  a  mean  of  54.7  g/day  (accounting  for  approxi-
ately  10%  of  their  daily  caloric  intake).127 Fructose  is
ependent  on  the  glucose  transporter  5  (GLUT5)  and  glu-
ose  transporter  2  (GLUT2)  for  passive  absorption.112 One
rospective  study  on  the  effect  of  low  lactose  and/or  fruc-
ose  diet,116 four  prospective  studies  on  the  effect  of  a  low
ructose  diet97,128,129 or  fructose  ingestion,130 and  two  ret-
ospective  studies124,131 on  the  effect  of  a low-fructose  diet
ave  been  conducted  in  children  (Table  2).
In  a  prospective  controlled  trial,97 103  children  with  AP-
GIDs  were  randomized  to  either  a fructose-restricted  diet
n  = 51)  or  a  no  dietary  intervention  group  (n  =  52)  for  two
eeks.  Lower  abdominal  pain  intensity,  but  not  frequency,
as  reported  by  those  children  on  the  fructose-restricted
iet  (irrespective  of  their  fructose  hydrogen  breath  test
esult).  In  a  prospective  observational  trial,129 75  chil-
ren  with  AP-FGIDs  and  positive  fructose  breath  test  on
 restricted  fructose  diet  showed  an  overall  reduction  on
he  abdominal  pain  frequency  and  pain  severity.129 Gomara
t  al.128 performed  fructose  hydrogen  breath  testing  using
arious  doses  of  fructose,  including  1  g,  15  g,  and  45  g in
2  children  with  an  AP-FGID.  They  found  that  11  (34%)  of
he  32  children  studied  had  fructose  malabsorption  either
ith  the  15  g  or  45  g  doses.  Following  a  two-week  dietitian-
ecommended  fructose-restricted  diet,  nine  out  of  these  11
82%)  had  a  signiﬁcant  improvement.128
Recently,  82  children  with  functional  abdominal  pain
isorders  whose  history  was  suggestive  for  a  possible  cor-
elation  with  ingestion  of  fructose  revealed  that  only  40%
f  them  had  malabsorption  deﬁned  by  increased  breath
ydrogen;  just  half  of  them  with  malabsorption  were
ymptomatic.  The  authors  suggested  that  visceral  hyper-
ensitivity,  rather  than  malabsorption  per  se,  may  correlate
ith  symptoms  in  some  patients.130 Escobar  et  al.131 com-
leted  fructose  breath  testing  using  1  g/kg  (up  to  25  g)  in  222
hildren  with  AP-FGIDs  and  found  that  121  out  of  222  chil-
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FODMAPs  and  functional  abdominal  pain  in  children  
dren  (55%)  had  fructose  malabsorption,  and  93  (77%)  of  them
improved  on  a  dietitian-recommended  low-fructose  diet.
In  a  retrospective  study,124 55/142  (39%)  children  had
fructose  malabsorption  identiﬁed  by  fructose  hydrogen
breath  testing,  but  several  also  showed  multiple  positive
carbohydrate  tests,  making  the  response  to  diet  unclear.  In
another  study122 involving  220  children  with  RAP,  some  chil-
dren  still  complained  of  abdominal  symptoms  when  using
milk  or  fructose-containing  food  despite  a  negative  double-
blind  placebo-controlled  provocation  test  with  lactose  or
fructose  (25%  with  milk  and  48%  with  fructose,  respectively).
Similarly  to  lactose,38,132 an  improvement  in  abdom-
inal  symptoms  has  been  reported  on  fructose-restricted
diet  regardless  of  the  presence  or  absence  of  fructose
malabsorption.91,133,134
Sorbitol-related  studies  in  children  with  FAPDs
No  prospective  studies  with  only  sorbitol  restriction
have  been  completed  in  children  with  AP-FGIDs,110 while
two  prospective  studies128,129 evaluated  a  combination  of
low--fructose  and  low-sorbitol  diet  (Table  2).
A  case  report135 described  a  15-year-old  girl  with  chronic
abdominal  pain,  most  likely  due  to  sorbitol  ingestion  from
sugar-free  gum,  which  improved  with  elimination  of  the  sor-
bitol  source.  In  a  retrospective  study,  Däbritz  et  al.124 found
that  109/146  (75%)  children  with  RAP  who  underwent  hydro-
gen  breath  testing  had  sorbitol  malabsorption,  and  27/31
(87%)  who  started  a  sorbitol-restricted  diet  reported  symp-
tom  improvement.
Discussion
A  signiﬁcant  beneﬁcial  effect  of  an  LFM  diet  on  clinical  symp-
toms  has  been  reported  by  several  studies  in  adults  with
IBS,37,97 while  in  children  there  is  currently  very  limited
data,  and  only  one  small  randomized  double-blind  study.  The
evidence  to  support  a  change  in  maternal  diet  for  the  treat-
ment  of  infantile  colic  is  also  weak.  Thus  more  research  is
needed  before  recommendations  in  children  can  be  made.
Due  to  the  complexity  of  designing  LFM  diets  and  the
potential  nutritional  imbalances,  guidance  by  professionals
with  expertise  in  dietary  management  is  important,  partic-
ularly  in  children  to  ensure  nutritional  adequacy  and  growth
potential.  It  is  currently  difﬁcult  to  predict  which  patients
would  beneﬁt  from  LFM  diets  because  of  the  lack  of  a  spe-
ciﬁc  biomarker  and  of  a  relation  between  breath  tests  and
improvement  of  symptoms.  When  clinicians  consider  LFM
diets,  they  should  be  aware  of  short-term  and  long-term  lim-
itations,  including  the  impact  on  quality  of  life  determined
by  multiple  restrictions,  the  possible  changes  in  gut  micro-
biota,  and  the  lack  of  knowledge  of  the  relative  efﬁcacy  in
children.
Gradual  reintroduction  of  FODMAPs  into  the  diet  after
the  elimination  phase  is  currently  recommended.82 This
approach  allows  a  personalized  diet  based  on  individual  tol-
erance  and  avoids  over-restriction  with  potential  nutritional
imbalances.  Supplementation  with  speciﬁc  probiotics  could
also  restore  the  gut  microbiota  altered  by  an  LFM  diet.83
Increasing  the  knowledge  regarding  FODMAP  content,
improving  the  foods  labeling,  and  analysis  are  important70 PRESS
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or  clinicians  and  dieticians  to  design  a  tailored  LFM  diet  and
or  the  patients  to  ease  the  dietary  compliance.
Further  research  is  still  needed  to  identify  the  best  way
o  reintroduce  foods  containing  FODMAPs  and  to  determine
hich  food  is  responsible  of  symptoms  for  each  patient.34
oreover,  additional  data  on  long-term  adherence,  effec-
iveness,  and  safety  are  also  needed.
Current  evidence  does  not  support  the  use  of  a  lactose-
estricted  diet  in  all  children  with  IBS.  Further  work  is
eeded  to  elucidate  the  role  of  exclusively  restricting  fruc-
ans  and  fructose  for  the  treatment  of  pediatric  FAPDs.
In  conclusion,  a  low  FODMAP  diet  is  a  promising  dietary
herapeutic  intervention  in  adults  with  IBS,  but  the  effec-
iveness  of  this  approach  in  children  with  IBS  and  FAPDs
emains  unclear.  Additional  efforts  are  still  needed  to  clarify
hich  patients  and  which  kind  of  FODMAP  restriction  would
eneﬁt  to  ensure  nutritional  adequacy,  to  facilitate  recog-
ition  of  FODMAP  content,  and  to  simplify  the  adherence  to
iet.
vailability of data and material
ata  sharing  not  applicable  to  this  article,  as  no  datasets
ere  generated  or  analyzed  during  the  current  study.
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